• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    3/12/24 2:07:31 PM ET
    $ACAD
    $ADM
    $AEVA
    $ASAN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Packaged Foods
    Consumer Staples
    Get the next $ACAD alert in real time by email

    Shares of Asana, Inc. (NYSE:ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

    Asana reported quarterly losses of 4 cents per share which beat the analyst consensus estimate of losses of 10 cents by 60%. Quarterly sales came in at $171.1 million, beating the analyst consensus estimate of $167.676 million by 2.04%.

    The company expects fiscal year 2025 adjusted losses of between 22 cents and 19 cents per share, versus the losses of 22 cents estimate and fiscal year revenues of between $716 million and $722 million, versus the $724.75 estimate.

    Asana shares dipped 11% to $16.72 on Tuesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • ClearOne, Inc. (NASDAQ:CLRO) rose 168.4% to $2.4299. ClearOne announced a special one-time cash dividend of 50 cents per share.
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) climbed 74.3% to $2.4050 after the company announced topline results from the second cohort of patients in its Phase 1b MAD study of RGLS8429 for the treatment of ADPKD. The company announced an oversubscribed $100 million private placement of equity.
    • Assure Holdings Corp. (NASDAQ:IONM) gained 49% to $0.4880. Assure Holdings entered into an agreement to sell certain of its assets to MPOWERHealth for up to $4.5 million.
    • Ranpak Holdings Corp. (NASDAQ:PACK) shares gained 40.1% to $6.12 after the company reported better-than-expected fourth-quarter revenue results and issued FY24 guidance. Also, Baird maintained an Outperform rating on the stock and raised its price target from $5 to $7.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) climbed 37.6% to $4.3321 after gaining over 6% on Monday.
    • Li-Cycle Holdings Corp. (NASDAQ:LICY) gained 27.4% to $0.5111 after the company entered an agreement to issue a senior secured convertible note in an aggregate principal amount of $75 million to an affiliate of Glencore.
    • Nukkleus Inc. (NASDAQ:NUKK) shares rose 22.5% to $1.41 after surging over 43% on Monday.
    • ATRenew Inc. (NYSE:RERE) gained 17.7% to $1.4003 after the company reported fourth-quarter results and announced a $20 million share repurchase program.
    • Lucas GC Limited (NASDAQ:LGCL) climbed 17.4% to $3.5099.
    • The Beachbody Company, Inc. (NYSE:BODI) gained 16.7% to $10.60 after the company reported better-than-expected fourth-quarter revenue results and issued first-quarter revenue guidance.
    • Assertio Holdings, Inc. (NASDAQ:ASRT) rose 15.6% to $1.08 following fourth-quarter earnings.
    • Kanzhun Limited (NASDAQ:BZ) gained 14.8% to $20.10 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter revenue guidance above estimates. The company approved a $200 million share buyback.
    • Heritage Insurance Holdings, Inc. (NYSE:HRTG) shares gained 13.4% to $8.11 following better-than-expected fourth-quarter results.
    • Datasea Inc. (NASDAQ:DTSS) gained 13.3% to $9.12.
    • Mission Produce, Inc. (NASDAQ:AVO) surged 12% to $11.98 following upbeat quarterly results.
    • Talkspace, Inc. (NASDAQ:TALK) jumped 11.3% to $3.25.
    • Bioventus Inc. (NASDAQ:BVS) gained 11.2% to $5.91 after the company reported better-than-expected fourth-quarter financial results and issued FY24 net sales guidance above estimates.
    • Bowman Consulting Group Ltd. (NASDAQ:BWMN) gained 11% to $37.33 following strong quarterly results.
    • Oracle Corporation (NYSE:ORCL) rose 10.5% to $126.09 after the company reported upbeat earnings for its fiscal third quarter.
    • Archer-Daniels-Midland Company (NYSE:ADM) jumped 5% to $57.63 after the company reported fourth-quarter financial results and issued FY24 guidance. Also, the company authorized the purchase an additional $2 billion of shares under its existing share repurchase program.
    • MINISO Group Holding Limited (NASDAQ:MNSO) shares gained 3% to $18.45 after posting stronger-than-expected quarterly earnings.

    Losers

    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) shares fell 71.5% to $0.0285 after the company announced pricing of $7.0 million underwritten public offering.
    • Simpple Ltd. (NASDAQ:SPPL) dipped 40.4% to $3.38.
    • Blade Air Mobility, Inc.. (NASDAQ:BLDE) fell 30.2% to $2.7850 after the company reported worse-than-expected fourth-quarter revenue results and issued FY24 revenue guidance below estimates.
    • Lexaria Bioscience Corp. (NASDAQ:LEXX) dipped 29.9% to $4.3787.
    • Jeffs' Brands Ltd (NASDAQ:JFBR) fell 29% to $0.4412.
    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) fell 28.3% to $0.48. NRx Pharmaceuticals initiated a strategy to combat short sellers in the company's stock.
    • Vincerx Pharma, Inc. (NASDAQ:VINC) fell 26.6% to $5.92.
    • Solidion Technology Inc. (NASDAQ:STI) fell 25.2% to $1.3093 after jumping 124% on Monday.
    • Caribou Biosciences, Inc. (NASDAQ:CRBU) fell 24.6% to $5.44 after the company reported worse-than-expected fourth-quarter financial results.
    • Renalytix Plc (NASDAQ:RNLX) fell 23.3% to $0.8732 after gaining around 5% on Monday. Renalytix recently received an unsolicited acquisition approach from a large, publicly-listed strategic diagnostics company and is evaluating an acquisition of the entire issued, and to be issued, the share capital of the company.
    • Nauticus Robotics, Inc. (NASDAQ:KITT) dipped 23% to $0.1820.
    • Presto Automation Inc. (NASDAQ:PRST) declined 22.7% to $0.2002.
    • Psyence Biomedical Ltd. (NASDAQ:PBM) fell 21.4% to $1.3900.
    • Canoo Inc. (NASDAQ:GOEV) declined 21.4% to $1.41.
    • SolarMax Technology, Inc. (NASDAQ:SMXT) declined 18.6% to $7.08.
    • Geron Corporation (NASDAQ:GERN) fell 17.5% to $1.7650 after FDA staff reviewers reportedly said treatment with the company's anemia drug Imetelstat is associated with risks that might be considered substantial.
    • Aeva Technologies, Inc. (NASDAQ:AEVA) dipped 16.7% to $1.0827.
    • ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) fell 15.8% to $20.31 after the company reported the Phase 3 ADVANCE-2 trial evaluating pimavanserin for the treatment of negative symptoms of schizophrenia did not meet the primary endpoint.
    • Finch Therapeutics Group, Inc. (NASDAQ:FNCH) dipped 14.9% to $2.91 after jumping over 36% on Monday.
    • Southwest Airlines Co. (NYSE:LUV) fell 14.5% to $28.88. Southwest Airlines said it sees first quarter 2024 RASM to be flat to up 2%, significantly lower than the prior estimate of up 2.5% to 4.5%.
    • CytomX Therapeutics, Inc. (NASDAQ:CTMX) shares dipped 14.3% to $2.14 following fourth-quarter results.
    • On Holding AG (NYSE:ONON) fell 13.7% to $29.01 after the company reported worse-than-expected quarterly financial results.
    • ESGL Holdings Limited (NASDAQ:ESGL) fell 13.4% to $0.5610.
    • Safe and Green Development Corporation (NASDAQ:SGD) declined 11.6% to $1.0250 after falling over 6% on Monday.
    • Kidpik Corp. (NASDAQ:PIK) shares tumbled 11.1% to $4.3314 after surging 80% on Monday.
    • Janux Therapeutics, Inc. (NASDAQ:JANX) declined 8.2% to $36.70.
    • Enphase Energy, Inc. (NASDAQ:ENPH) fell 5.7% to $121.41.
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) shares fell 4.9% to $9.26 after the company reported worse-than-expected fourth-quarter financial results.

     

    Now Read This: Bitcoin Surpasses $72,000 Following Inflation Data; Toncoin Emerges As Top Gainer

    Get the next $ACAD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACAD
    $ADM
    $AEVA
    $ASAN

    CompanyDatePrice TargetRatingAnalyst
    Bioventus Inc.
    $BVS
    3/27/2026$14.00Market Outperform
    CJS Securities
    On Holding AG
    $ONON
    3/25/2026$65.00 → $60.00Outperform
    Telsey Advisory Group
    ACADIA Pharmaceuticals Inc.
    $ACAD
    3/25/2026$29.00Neutral → Buy
    BofA Securities
    Oracle Corporation
    $ORCL
    3/24/2026$200.00Buy
    BofA Securities
    CytomX Therapeutics Inc.
    $CTMX
    3/16/2026$12.00Neutral → Overweight
    Analyst
    Oracle Corporation
    $ORCL
    3/11/2026$210.00Neutral → Overweight
    Analyst
    Oracle Corporation
    $ORCL
    3/11/2026$205.00 → $200.00Outperform
    BMO Capital Markets
    Oracle Corporation
    $ORCL
    3/11/2026$185.00 → $210.00Outperform
    Oppenheimer
    More analyst ratings

    $ACAD
    $ADM
    $AEVA
    $ASAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Jiong Ng Chee

    3 - Singularity Future Technology Ltd. (0001422892) (Issuer)

    3/27/26 10:09:32 AM ET
    $SGLY
    Integrated Freight & Logistics
    Industrials

    SEC Form 4 filed by Chen Kerry Xuefeng

    4 - ATRenew Inc. (0001838957) (Issuer)

    3/26/26 9:26:01 PM ET
    $RERE
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Thompson Elizabeth H.Z.

    4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)

    3/26/26 8:00:12 PM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $ADM
    $AEVA
    $ASAN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CJS Securities initiated coverage on Bioventus with a new price target

    CJS Securities initiated coverage of Bioventus with a rating of Market Outperform and set a new price target of $14.00

    3/27/26 9:18:56 AM ET
    $BVS
    Medical/Dental Instruments
    Health Care

    Telsey Advisory Group reiterated coverage on On with a new price target

    Telsey Advisory Group reiterated coverage of On with a rating of Outperform and set a new price target of $60.00 from $65.00 previously

    3/25/26 10:11:48 AM ET
    $ONON
    Shoe Manufacturing
    Consumer Discretionary

    ACADIA Pharmaceuticals upgraded by BofA Securities with a new price target

    BofA Securities upgraded ACADIA Pharmaceuticals from Neutral to Buy and set a new price target of $29.00

    3/25/26 8:22:46 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $ADM
    $AEVA
    $ASAN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Jeffs' Brands: KeepZone AI Enters into Agent Agreement with Skyline Software Systems to Offer 3D Geospatial Visualization Solutions to Global Security Markets

    Tel Aviv, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd ("Jeffs' Brands" or the "Company") (NASDAQ:JFBR, JFBRW)), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence ("AI") – driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. ("KeepZone"), has entered into a non-exclusive Agent Agreement (the "Agreement") with Skyline Software Systems, Inc. ("Skyline"), a  leading provider of 3D geospatial visualization software and services. Under the terms of the Agreement, KeepZone is authorized to market, sell, and distribute Skyline's proprieta

    3/27/26 8:55:00 AM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    BOSS Zhipin Continued Share Repurchase, Total Repurchases Amount to Over RMB500 million in 2026

    BEIJING, March 27, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing around RMB23.6 million to repurchase 506,252 ordinary shares on March 26. Year-to-date in 2026, the Company has deployed over RMB500 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns. CONTACT: PIACENTE·FINANCIAL COMMUNICATIONS [email protected]

    3/27/26 7:00:00 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    Oracle Scales Up Nashville Offices to Support Rapid Growth

    New lease at the Neuhoff Development adds over 116,000 square feet to Oracle's Nashville footprintAUSTIN, Texas, March 26, 2026 /PRNewswire/ -- To accommodate future growth of its Nashville workforce, Oracle has signed a new 116,000 square foot lease within The Neuhoff District, at 1320 Adams Street. With this latest investment, Oracle will bring its office capacity in Nashville to about 2,000 seats across three locations, marking significant progress in the company's plans to create thousands of new tech jobs and become a cornerstone of the local economy. "New candidates as wel

    3/26/26 6:49:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACAD
    $ADM
    $AEVA
    $ASAN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    FDA Approval for RYTELO issued to GERON CORP

    Submission status for GERON CORP's drug RYTELO (ORIG-1) with active ingredient IMETELSTAT has changed to 'Approval' on 06/06/2024. Application Category: NDA, Application Number: 217779, Application Classification: Type 1 - New Molecular Entity

    6/7/24 12:36:59 PM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-9) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 210793, Application Classification: Efficacy

    9/18/23 10:47:05 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $ADM
    $AEVA
    $ASAN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Talkspace Inc.

    SCHEDULE 13G/A - Talkspace, Inc. (0001803901) (Subject)

    3/27/26 1:17:24 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Oracle Corporation

    SCHEDULE 13G/A - ORACLE CORP (0001341439) (Subject)

    3/27/26 11:08:37 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Ocular Therapeutix Inc.

    SCHEDULE 13G/A - OCULAR THERAPEUTIX, INC (0001393434) (Subject)

    3/27/26 11:06:43 AM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $ADM
    $AEVA
    $ASAN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Globalharvest Holdings Venture Ltd bought $2,583,903 worth of shares (217,274 units at $11.89), increasing direct ownership by 2% to 9,987,882 units (SEC Form 4)

    4 - Mission Produce, Inc. (0001802974) (Issuer)

    3/17/26 4:54:51 PM ET
    $AVO
    Farming/Seeds/Milling
    Consumer Staples

    Large owner First Finance Ltd. bought $1,750,000 worth of shares (437,500 units at $4.00), increasing direct ownership by 36% to 1,641,162 units (SEC Form 4)

    4 - CLEARONE INC (0000840715) (Issuer)

    3/6/26 6:02:39 AM ET
    $CLRO
    Telecommunications Equipment
    Utilities

    Director Lindstrom Richard L Md bought $461,354 worth of shares (60,229 units at $7.66), increasing direct ownership by 32% to 246,933 units (SEC Form 4)

    4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)

    2/24/26 6:13:03 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $ADM
    $AEVA
    $ASAN
    Financials

    Live finance-specific insights

    View All

    Nauticus Robotics, Inc. Announces Timing of 2025 Year-End Investor Earnings Conference Call

    HOUSTON, March 26, 2026 /PRNewswire/ -- Nauticus Robotics, Inc. (NASDAQ:KITT, ", Nauticus", or ", Company", )) today announced the Company's schedule for conducting its financial and operating results call for the year ended December 31, 2025.  The Company plans to host an earnings conference call on April 02, 2026 at 9:00 am Central Time.To participate in the earnings conference call, participants should dial toll free at +1-800-715-9871, conference ID: 9197689, or access the listen-only webcast at the following link: https://events.q4inc.com/attendee/633198435.About Nauticus R

    3/26/26 8:55:00 AM ET
    $KITT
    Industrial Machinery/Components
    Industrials

    BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

    BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing around RMB34.4 million to repurchase 748,552 ordinary shares on March 24. Year-to-date in 2026, the Company has deployed nearly RMB450 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns. On March 18, 2026, the Company's board of directors (the "Board") approved amendments to the existing share repurchase program, increasing the total authorization under the program to repurchase up to US$400 million of the Company's shares (including

    3/25/26 6:30:00 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

    Key highlights for the first full year of operation under the new management team include: A year-over-year reduction in operating expenses with $7.8 Million cash on hand at year end. With ongoing revenue from operations and current ATM trends, the Company anticipates adequate resources to support operations through 2026, with anticipation of continued revenue growth. As of December 31, 2025, all previously issued convertible debt had been converted into common stock.Anticipated FDA approval of at least one new drug – Preservative Free Ketamine under an ANDA—during Q3 2026. A favorable preliminary bioequivalence determination was received from the FDA last week.A Type C in-person meeting wi

    3/24/26 7:00:00 AM ET
    $NRXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $ADM
    $AEVA
    $ASAN
    Leadership Updates

    Live Leadership Updates

    View All

    Oracle Scales Up Nashville Offices to Support Rapid Growth

    New lease at the Neuhoff Development adds over 116,000 square feet to Oracle's Nashville footprintAUSTIN, Texas, March 26, 2026 /PRNewswire/ -- To accommodate future growth of its Nashville workforce, Oracle has signed a new 116,000 square foot lease within The Neuhoff District, at 1320 Adams Street. With this latest investment, Oracle will bring its office capacity in Nashville to about 2,000 seats across three locations, marking significant progress in the company's plans to create thousands of new tech jobs and become a cornerstone of the local economy. "New candidates as wel

    3/26/26 6:49:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Geron Announces Appointment of New Members to its Board of Directors

    FOSTER CITY, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Patricia S. Andrews and Constantine Chinoporos to its Board of Directors. "We are pleased to welcome Constantine and Pat to the Board, as they bring deep operational expertise cultivated over decades of biopharmaceutical industry leadership, particularly with commercial-stage organizations," said Elizabeth O'Farrell, Chair of the Board. "Their invaluable insights will be instrumental as we execute on our strategic priorities and drive commercial growth for RYTE

    3/26/26 8:00:00 AM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    $ACAD
    $ADM
    $AEVA
    $ASAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Psyence Biomedical Ltd.

    SC 13G - PSYENCE BIOMEDICAL LTD. (0001985062) (Subject)

    12/13/24 9:16:01 AM ET
    $PBM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Blade Air Mobility Inc.

    SC 13G/A - Blade Air Mobility, Inc. (0001779128) (Subject)

    12/10/24 1:28:44 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Li-Cycle Holdings Corp.

    SC 13D/A - Li-Cycle Holdings Corp. (0001828811) (Subject)

    12/9/24 6:03:27 PM ET
    $LICY
    Environmental Services
    Industrials

    $ACAD
    $ADM
    $AEVA
    $ASAN
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Assertio Holdings Inc. on Jun 6

    Recent insider transactions at Assertio Holdings Inc. have brought attention to the company's stock activity. On June 6, 2024, Mason Heather L purchased $24,250 worth of shares, acquiring 25,000 units at $0.97 per share. This transaction increased Mason Heather L's direct ownership by 13% to 212,650 units, as reported in the SEC Form 4. Several other notable insider transactions have taken place at Assertio Holdings Inc. leading up to this purchase. Patel Ajay, Schwichtenberg Paul, and Schlessinger Sam all converted options into shares and covered exercise/tax liability by utilizing their shares. These transactions resulted in ownership increases of 16%, 20%, and 21%, respectively. Addition

    6/10/24 1:20:50 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care